PL1940349T3 - Preparat aerozolowy do inhalacji beta agonistów - Google Patents
Preparat aerozolowy do inhalacji beta agonistówInfo
- Publication number
- PL1940349T3 PL1940349T3 PL06807028T PL06807028T PL1940349T3 PL 1940349 T3 PL1940349 T3 PL 1940349T3 PL 06807028 T PL06807028 T PL 06807028T PL 06807028 T PL06807028 T PL 06807028T PL 1940349 T3 PL1940349 T3 PL 1940349T3
- Authority
- PL
- Poland
- Prior art keywords
- inhalation
- aerosol formulation
- beta agonists
- agonists
- beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05109376 | 2005-10-10 | ||
| PCT/EP2006/067126 WO2007042468A2 (de) | 2005-10-10 | 2006-10-06 | Aerosolformulierung für die inhalation von betaagonisten |
| EP06807028.3A EP1940349B1 (de) | 2005-10-10 | 2006-10-06 | Aerosolformulierung für die inhalation von betaagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1940349T3 true PL1940349T3 (pl) | 2018-07-31 |
Family
ID=35241312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06807028T PL1940349T3 (pl) | 2005-10-10 | 2006-10-06 | Preparat aerozolowy do inhalacji beta agonistów |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US20070088030A1 (pl) |
| EP (1) | EP1940349B1 (pl) |
| JP (1) | JP2009511542A (pl) |
| KR (1) | KR20080059290A (pl) |
| CN (1) | CN101282712A (pl) |
| AR (1) | AR058082A1 (pl) |
| AU (1) | AU2006301330B9 (pl) |
| BR (1) | BRPI0617278A2 (pl) |
| CA (1) | CA2624786C (pl) |
| CY (1) | CY1120199T1 (pl) |
| DK (1) | DK1940349T3 (pl) |
| EA (1) | EA200800927A1 (pl) |
| EC (1) | ECSP088294A (pl) |
| ES (1) | ES2668364T3 (pl) |
| HR (1) | HRP20180713T1 (pl) |
| HU (1) | HUE039186T2 (pl) |
| IL (1) | IL190682A (pl) |
| LT (1) | LT1940349T (pl) |
| MY (1) | MY163503A (pl) |
| NO (1) | NO343363B1 (pl) |
| NZ (1) | NZ567545A (pl) |
| PE (1) | PE20070708A1 (pl) |
| PL (1) | PL1940349T3 (pl) |
| PT (1) | PT1940349T (pl) |
| RS (1) | RS57085B1 (pl) |
| SI (1) | SI1940349T1 (pl) |
| TW (1) | TWI389692B (pl) |
| UA (1) | UA99250C2 (pl) |
| UY (1) | UY29844A1 (pl) |
| WO (1) | WO2007042468A2 (pl) |
| ZA (1) | ZA200801390B (pl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7056916B2 (en) * | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US20050272726A1 (en) * | 2004-04-22 | 2005-12-08 | Boehringer Ingelheim International Gmbh | Novel medicaments for the treatment of respiratory diseases |
| US20050255050A1 (en) * | 2004-05-14 | 2005-11-17 | Boehringer Ingelheim International Gmbh | Powder formulations for inhalation, comprising enantiomerically pure beta agonists |
| US20050256115A1 (en) * | 2004-05-14 | 2005-11-17 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta-agonists |
| US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| BRPI0614410A2 (pt) * | 2005-08-15 | 2011-03-29 | Boehringer Ingelheim Int | processo para preparação de betamiméticos |
| US20110281858A1 (en) * | 2008-11-21 | 2011-11-17 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta agonists |
| WO2010057927A1 (en) * | 2008-11-21 | 2010-05-27 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta agonists |
| GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
| GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| WO2014016548A2 (en) | 2012-07-27 | 2014-01-30 | Cipla Limited | Pharmaceutical composition |
| WO2014056840A1 (en) * | 2012-10-09 | 2014-04-17 | Boehringer Ingelheim International Gmbh | Beta-2-adrenoceptor agonist for the treatment of cough |
| US20140235627A1 (en) * | 2012-12-21 | 2014-08-21 | Boehringer Ingelheim International Gmbh | ß2-ADRENOCEPTOR AGONIST FOR IMPROVEMENT OF EXERCISE TOLERANCE |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
| EA036707B1 (ru) * | 2015-05-18 | 2020-12-10 | Гленмарк Спешелти С.А. | Ингаляционный раствор тиотропия для небулайзерного распыления |
| JP2019536812A (ja) | 2016-12-12 | 2019-12-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | オロダテロールとの同時投与による間質性肺疾患の処置方法に使用するためのニンテダニブ |
| US20210322311A1 (en) * | 2020-04-16 | 2021-10-21 | Cai Gu Huang | Inhalable Formulation of a Solution Containing Tiotropium Bromide and Olodaterol |
| CN115703121A (zh) * | 2021-08-07 | 2023-02-17 | 广州谷森制药有限公司 | 一种含噻托溴铵、奥达特罗药品制剂和除醛包材容器的组合 |
| CN114259481A (zh) * | 2021-11-26 | 2022-04-01 | 南京华盖制药有限公司 | 一种奥达特罗复方吸入溶液 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3134590A1 (de) * | 1981-09-01 | 1983-03-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue benzo-heterocyclen |
| DE3931041C2 (de) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| ATE177941T1 (de) * | 1992-12-09 | 1999-04-15 | Boehringer Ingelheim Pharma | Stabilisierte medizinische aerosollösungen |
| SK15382002A3 (sk) * | 2000-04-27 | 2003-03-04 | Boehringer Ingelheim Pharma Kg | Betamimetiká, farmaceutický prostriedok s ich obsahom a ich použitie |
| DE10216036A1 (de) | 2002-04-11 | 2003-10-23 | Boehringer Ingelheim Pharma | Aerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz |
| DE10253282A1 (de) | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
| US7056916B2 (en) * | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US7244728B2 (en) * | 2004-03-17 | 2007-07-17 | Boehringer Ingelheim International Gmbh | Long acting betamimetics for the treatment of respiratory diseases |
| US20050239778A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim International Gmbh | Novel medicament combinations for the treatment of respiratory diseases |
| US20050272726A1 (en) * | 2004-04-22 | 2005-12-08 | Boehringer Ingelheim International Gmbh | Novel medicaments for the treatment of respiratory diseases |
| DK2422786T3 (da) * | 2004-04-22 | 2014-11-17 | Boehringer Ingelheim Int | Nye lægemiddelkombinationer til behandling af luftvejssygdomme |
| US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| US20050255050A1 (en) * | 2004-05-14 | 2005-11-17 | Boehringer Ingelheim International Gmbh | Powder formulations for inhalation, comprising enantiomerically pure beta agonists |
| US20050256115A1 (en) * | 2004-05-14 | 2005-11-17 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta-agonists |
-
2006
- 2006-10-05 US US11/543,477 patent/US20070088030A1/en not_active Abandoned
- 2006-10-05 TW TW095137046A patent/TWI389692B/zh active
- 2006-10-06 PT PT68070283T patent/PT1940349T/pt unknown
- 2006-10-06 UA UAA200805249A patent/UA99250C2/ru unknown
- 2006-10-06 AR ARP060104405A patent/AR058082A1/es not_active Application Discontinuation
- 2006-10-06 JP JP2008535001A patent/JP2009511542A/ja active Pending
- 2006-10-06 NZ NZ567545A patent/NZ567545A/en unknown
- 2006-10-06 KR KR1020087011009A patent/KR20080059290A/ko not_active Ceased
- 2006-10-06 HR HRP20180713TT patent/HRP20180713T1/hr unknown
- 2006-10-06 LT LTEP06807028.3T patent/LT1940349T/lt unknown
- 2006-10-06 MY MYPI20081057A patent/MY163503A/en unknown
- 2006-10-06 BR BRPI0617278-4A patent/BRPI0617278A2/pt not_active Application Discontinuation
- 2006-10-06 RS RS20180434A patent/RS57085B1/sr unknown
- 2006-10-06 EP EP06807028.3A patent/EP1940349B1/de active Active
- 2006-10-06 AU AU2006301330A patent/AU2006301330B9/en active Active
- 2006-10-06 PL PL06807028T patent/PL1940349T3/pl unknown
- 2006-10-06 UY UY29844A patent/UY29844A1/es not_active Application Discontinuation
- 2006-10-06 WO PCT/EP2006/067126 patent/WO2007042468A2/de not_active Ceased
- 2006-10-06 PE PE2006001218A patent/PE20070708A1/es not_active Application Discontinuation
- 2006-10-06 EA EA200800927A patent/EA200800927A1/ru unknown
- 2006-10-06 HU HUE06807028A patent/HUE039186T2/hu unknown
- 2006-10-06 SI SI200632255T patent/SI1940349T1/en unknown
- 2006-10-06 DK DK06807028.3T patent/DK1940349T3/en active
- 2006-10-06 ES ES06807028.3T patent/ES2668364T3/es active Active
- 2006-10-06 CN CNA2006800377251A patent/CN101282712A/zh active Pending
- 2006-10-06 CA CA2624786A patent/CA2624786C/en not_active Expired - Fee Related
-
2008
- 2008-02-11 ZA ZA200801390A patent/ZA200801390B/xx unknown
- 2008-02-14 NO NO20080801A patent/NO343363B1/no unknown
- 2008-03-19 EC EC2008008294A patent/ECSP088294A/es unknown
- 2008-04-08 IL IL190682A patent/IL190682A/en active IP Right Grant
-
2009
- 2009-09-22 US US12/564,477 patent/US20100009984A1/en not_active Abandoned
-
2011
- 2011-04-14 US US13/087,009 patent/US20110190284A1/en not_active Abandoned
-
2018
- 2018-05-10 CY CY20181100484T patent/CY1120199T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200801390B (en) | Aerosol formulation for the inhalation of beta agonists | |
| IL197025A0 (en) | Aerosol formulation for the inhalation of beta agonists | |
| IL197024A0 (en) | Aerosol formulation for the inhalation of beta agonists | |
| IL191809A0 (en) | Powder compositions for inhalation | |
| ZA200808530B (en) | Pharmaceutical composition for external use | |
| IL198289A (en) | Processed dihydropyrazolones, processes for their preparation, medicinal preparations containing them and their use in the preparation of medicinal preparations | |
| IL189856A0 (en) | New formulation | |
| ZA200808531B (en) | Pharmaceutical composition for external use | |
| SI1874746T1 (sl) | Derivati 1-N-azacikloalkil-3-fenoksipropana za uporabo pri pripravi psihotropičnih zdravil | |
| ZA200707565B (en) | Aerosol insecticide composition | |
| ZA200903840B (en) | Powder formulation for valganciclovir | |
| IL194961A0 (en) | Compounds a-r-x for the manufacture of pharmaceutical preparations | |
| ZA200903049B (en) | Polymer-linked-bisphosphonate inhalant formulations and methods for using the same | |
| ZA200806929B (en) | Nebulizer formulation | |
| IL213474A0 (en) | Processes for the preparation of cyclopropyl-amide derivatives | |
| SG152265A1 (en) | Aerosol formulation for inhalation of beta agonists | |
| PL2167042T3 (pl) | Kompozycje farmaceutyczne w aerozolu zawierające flutykazon | |
| ZA200900370B (en) | Aerosol formulation for the inhalation of beta agonists | |
| EP1849481A4 (en) | COMPOSITION FOR TOPICAL APPLICATION | |
| ZA200704977B (en) | Nebulizer formulation | |
| ZA200900418B (en) | Aerosol formulation for the inhalation of beta agonists | |
| ZA200606181B (en) | Aerosol formulation | |
| GB0519083D0 (en) | Compositions for the improved delivery of medicaments | |
| PL376552A1 (pl) | Środek do zwalczania zagrożeń pyłowych | |
| GB0525842D0 (en) | Improved compositions for inhalation |